Fulminant guillain-barré syndrome with myocarditis

Ajay Mishra1, Nikhil Dave1, Manan Mehta1

  • 1Department of Medicine, Pramukhswami Medical College, Karamsad, Gujarat, India.

Insights

Guillain-Barré syndrome (GBS) is a varied neurological disorder. This report details a rare, fatal case of fulminant GBS complicated by myocarditis.

Area of Science:

  • Neurology
  • Immunology
  • Cardiology

Background:

  • Guillain-Barré syndrome (GBS) is a group of rare neurological disorders characterized by the immune system attacking the peripheral nervous system.
  • GBS presents with diverse clinical manifestations, varying in severity and presentation patterns.
  • Understanding the full spectrum of GBS, including rare complications, is crucial for effective management.

Observation:

  • A rare case of fulminant Guillain-Barré syndrome is presented.
  • The patient developed myocarditis during the course of the illness.
  • The case resulted in a fatal outcome.

Findings:

  • Fulminant GBS can present with severe and rapid progression.
  • Myocarditis is a rare but serious complication of GBS.
  • The combination of fulminant GBS and myocarditis carries a high mortality risk.

Implications:

  • This case highlights the critical importance of recognizing and managing cardiac complications in severe GBS.
  • Early diagnosis and aggressive treatment of myocarditis in GBS patients may improve outcomes.
  • Further research into the pathophysiological links between GBS and myocarditis is warranted.

Related Concept Videos

Myocarditis II: Clinical Features and Diagnostic Tests01:27

Myocarditis II: Clinical Features and Diagnostic Tests

Myocarditis is an inflammation of the heart muscle. The symptoms vary widely, encompassing asymptomatic presentations to severe, acute manifestations.Clinical PresentationAsymptomatic cases: In some instances, myocarditis may be asymptomatic, with the infection resolving without intervention. These cases often go undetected unless discovered incidentally through diagnostic imaging or tests conducted for other reasons.General Early Symptoms: Early symptoms of myocarditis are non-specific and can...
493
Myocarditis I: Introduction01:21

Myocarditis I: Introduction

Myocarditis is inflammation of the myocardium, which is the muscular layer of the heart.EtiologyMyocarditis has a diverse etiology, including a wide range of infectious and non-infectious causes:Infectious CausesViral: Common viruses include Coxsackie A and B, adenovirus, parvovirus B19, enteroviruses, and influenza A.Bacterial: Examples include infections caused by Streptococcus, Staphylococcus, and Mycoplasma species.Rickettsial: Infections like Rocky Mountain spotted fever can result in...
645
Myocarditis III: Medical Management01:14

Myocarditis III: Medical Management

Myocarditis: Comprehensive Medical ManagementMyocarditis, the heart muscle inflammation, requires a comprehensive medical management strategy that addresses the underlying cause, provides supportive care, manages symptoms, and reduces cardiac workload.Infections and Autoimmune CausesAdminister appropriate antimicrobial therapy when an infectious agent causes myocarditis. For instance, penicillin treats infections caused by Group A Streptococcus. In cases where autoimmune processes are...
343
Myocarditis IV: Nursing Management01:22

Myocarditis IV: Nursing Management

Myocarditis is an inflammatory condition of the myocardium requiring meticulous nursing management for optimal patient outcomes. Effective management begins with a thorough assessment of the patient's medical history, paying close attention to past infections, autoimmune disorders, travel history, and exposure to toxins or drugs. Recent viral infections and systemic diseases are particularly relevant due to their potential role in triggering myocarditis.Physical Examination and MonitoringThe...
398
Myasthenia Gravis ll: Pathophysiology01:22

Myasthenia Gravis ll: Pathophysiology

The disease process of myasthenia gravis begins at the neuromuscular junction, where antibodies attack key proteins needed for muscle activation. This immune reaction weakens signal transmission, leading to the characteristic muscle fatigue and weakness that define the condition.Immune-Mediated DamageIn most individuals, antibodies target acetylcholine receptors (AChRs) on the postsynaptic membrane of muscle cells. By blocking acetylcholine binding, these antibodies prevent the nerve signal...
53
Diphtheria01:28

Diphtheria

Diphtheria is an acute, toxin-mediated infectious disease that primarily affects the upper respiratory tract. It is caused by Corynebacterium diphtheriae, a Gram-positive, pleomorphic rod that lacks spore-forming capability and exhibits a characteristic club-shaped morphology under microscopic examination. While C. diphtheriae can asymptomatically colonize mucosal surfaces, clinical disease manifests only when the bacterial strain is lysogenized by a specific β-corynephage. This phage...
175